Barrier creams: Facts and controversies

Dermatitis

Volumn 25, Issue 6, 2014, Pages 327-333

  Corazza, Monica ^a   Minghetti, Sara ^a   Bianchi, Anna ^a   Virgili, Annarosa ^a   Borghi, Alessandro ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; EMOLLIENT AGENT; HUMECTANT; SKIN CREAM;

BARRIER CREAM; CREAM; DRUG FORMULATION; FOOD AND DRUG ADMINISTRATION; HUMAN; HYDRATION; HYDROGEL; MEDICAL DEVICE; PRESCRIPTION; PRIORITY JOURNAL; PRODUCT SAFETY; REVIEW; SKIN PROTECTION; SKIN WATER LOSS; DERMATITIS, CONTACT;

DERMATITIS, CONTACT; EMOLLIENTS; HUMANS; SKIN CREAM;

EID: 84928111214     PISSN: 17103568     EISSN: 21625220     Source Type: Journal    
DOI: 10.1097/DER.0000000000000078     Document Type: Review

References (75)

1. Proksch E, Lachapelle JM. The management of dry skin with topical emollientsVrecent perspectives. J Dtsch Dermatol Ges 2005;3:768-774.
2. Elias PM. Stratum corneum defensive functions: An integrated view. J Invest Dermatol 2005;125:183-200.
3. Barco D, Giménez-Arnau A. Xerosis: A dysfunction of the epidermal barrier. Actas Dermosifiliogr 2008;99:671-682.
4. Draelos ZD. New treatments for restoring impaired epidermal barrier permeability: skin barrier repair creams. Clin Dermatol 2012;30:345-348.
5. Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003;4:771-788.
6. Kraft JN, Lynde CW. Moisturizers: what they are and a practical approach to product selection. Skin Therapy Lett 2005;10:1-8.
7. Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther 2004;17:43-48.
8. Nakagawa N, Sakai S, Matsumoto M, et al. Relationship between NMF (lactate and potassium) content and the physical properties of the stratum corneum in healthy subjects. J Invest Dermatol 2004;122:755-763.
9. Jokura Y, Ishikawa S, Tokuda H, et al. Molecular analysis of elastic properties of the stratum corneum by solid-state 13C-nuclear magnetic resonance spectroscopy. J Invest Dermatol 1995;104:806-812.
10. Clark C. How to choose a suitable emollient. Pharm J 2004;273:351-353.
11. Proksch E, Brasch J. Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clin Dermatol 2012;30:335-344.
12. Antezana M, Parker F. Occupational contact dermatitis. Immunol Allergy Clin North Am 2003;23:269-290.
13. Nielsen JB, Nielsen F, Sørensen JA. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin. Arch Dermatol Res 2007;299:423-431.
14. Slodownik D, Nixon R. Occupational factors in skin diseases. Curr Probl Dermatol 2007;35:173-189.
15. Fluhr JW, Darlenski R, Angelova-Fischer I, et al. Skin irRITation and sensitization: mechanisms and new approaches for risk assessment. Skin Pharmacol Physiol 2008;21:124-135.
16. Wigger-Alberti W, Maraffio B, Wernli M, et al. Self-application of a protective cream. Pitfalls of occupational skin protection. Arch Dermatol 1997;133:861-864.
17. Alvarez MS, Brown LH, Brancaccio RR. Are barrier creams actually effective? Curr Allergy Asthma Rep 2001;1:337-341.
18. Frosch PJ, Schulze-Dirks A, Hoffmann M, et al. Efficacy of skin barrier creams (II). Ineffectiveness of a popular "skin protector" against various irRITants in the repetitive irRITation test in the guinea pig. Contact Dermatitis 1993;29:74-77.
19. Title 21VFood And Drugs Chapter IVFood And Drug Administration, Department of Health and Human Services Subchapter HVMedical Devices PART 860. Medical Device Classification Procedures. CFRVCode of Federal Regulations Title 21. U.S.
20. Council Directive 93/42/EEC of 14 June 1993 Concerning Medical Devices, OJ L 169 of 12 July 1993.
21. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on Cosmetic Products, Official Journal of the European Union, L 342/59, 22-12-2009.
22. Guidelines to Commission Regulation (EU) No 655/2013 Laying Down Common CRITeria for the Justification of Claims Used in Relation to Cosmetic Products, July 2013.
23. Lodén M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol 2005;19:672-688.
24. Paye M, Barel MO, Maibach HI. Handbook of Cosmetic Science and Technology. Boca Raton, Florida: Taylor & Francis Group; 2006.
25. Juch RD, Rufli T, Surber C. Pastes: what do they contain? How do they work? Dermatology 1994;189:373-377.
26. Arzhavitina A, Steckel H. Foams for pharmaceutical and cosmetic application. Int J Pharm 2010;394:1-17.
27. Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph. Federal Register. June 4, 2003; Vol. 68, No. 107:33362-33380. Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm070833.htm.
28. Mao-Qiang M, Brown BE, Wu-Pong S, et al. Exogenous non-physiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 1995;131:809-816.
29. Lodén Marie. Effect of moisturizers on epidermal barrier function. Clin Dermatol 2012;30:286-296.
30. Held E, Lund H, Agner T. Effect of different moisturizers on SLS-irRITated human skin. Contact Dermatitis 2001;44:229-234.
31. Meckfessel MH, Brandt S. The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products. J Am Acad Dermatol 2014;71:177-184.
32. Zettersten EM, Ghadially R, Feingold KR, et al. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J Am Acad Dermatol 1997;37:403-408.
33. Lodén M, Barany E. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. Acta Derm Venereol 2000;80:412-415.
34. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002;47:198-208.
35. Saary J, Qureshi R, Palda V, et al. A systematic review of contact dermatitis treatment and prevention, J Am Acad Dermatol 2005;53:845-855.
36. Kircik LH, Del Rosso JQ, Aversa D. Evaluating clinical use of a ceramidedominant, physiologic lipid-based topical emulsion for atopic dermatitis, J Clin Aesthet Dermatol 2011;4:34-40.
37. Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Dermatol Ther 2004;17:49-56.
38. Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and functions. Br J Dermatol 2008;159:23-34.
39. Becker LC, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of allantoin and its related complexes. Int J Toxicol 2010;29:84S-97S.
40. Visscher MO, Tolia GT, Wickett RR, et al. Effect of soaking and natural moisturizing factor on stratum corneum water-handling properties. J Cosmet Sci 2003;54:289-300.
41. Lembo S, Lembo C, Lo Conte V, et al. In vivo evaluation of a Poly-2p barrier cream protective effect. G Ital Dermatol Venereol 2010;145:703-708.
42. Millerioux J, Cruz C, Bazire A, et al. In vitro selection and efficacy of topical skin protectants against the nerve agent VX. Toxicol In Vitro 2009;23:539-545.
43. Schliemann-Willers S. Efficacy of a new class of perfluoropolyethers in the prevention of irRITant contact dermatitis. Acta Derm Venereol 2001; 81:392-394.
44. Elsner P, Wigger-Alberti W, Pantini G. Perfluoropolyethers in the prevention of irRITant contact dermatitis. Dermatology 1998;197:141-145.
45. Berndt U, Wigger-Alberti W, Gabard B, et al. Efficacy of a barrier cream and its vehicle as protective measures against occupational irRITant contact dermatitis. Contact Dermatitis 2000;42:77-80.
46. Smolik S, Chodurek E, Nogaj P, et al. Characteristics of chelation ability of chosen metal ions by protective ointments containing NA2H2EDTA .Acta Pol Pharm 2008;65:125-128.
47. Frosch PJ, Kurte A. Contact efficacy of skin barrier creams (IV). The repetitive irRITation test (RIT) with a set of 4 standard irRITants. Contact Dermatitis 1994;31:161-168.
48. Schliemann S, Petri M, Elsner P. Preventing irRITant contact dermatitis with protective creams: influence of the application dose. Contact Dermatitis 2014;70:19-26.
49. Schliemann S, Petri M, Elsner P. How much skin protection cream is actually applied in the workplace? Determination of dose per skin surface area in nurses. Contact Dermatitis 2012;67:229-233.
50. Wigger-Alberti W, Maraffio B, Wernli M, et al. Training workers at risk for occupational contact dermatitis in the application of protective creams: efficacy of a fluorescence technique. Dermatology 1997;195:129-133.
51. Hogan DJ, Dannaker CJ, Lal S, et al. An international survey on the prognosis of occupational contact dermatitis of the hands. Derm Beruf Umwelt 1990;38:143-147.
52. Ramsing DW, Agner T. Preventive and therapeutic effects of a moisturizer. An experimental study of human skin. Acta Derm Venereol 1997;77: 335-337.
53. Zhai H, Maibach HI. Moisturizers in preventing irRITant contact dermatitis: An overview. Contact Dermatitis 1998;38:241-244.
54. Hannuksela A, Kinnunen T. Moisturizers prevent irRITant dermatitis. Acta Derm Venereol 1992;72:42-44.
55. Blanken R, van Vilsteren MJ, Tupker RA, et al. Effect of mineral oil and linoleic-acidYcontaining emulsions on the skin vapour loss of sodiumlauryl- sulphateYinduced irRITant skin reactions. Contact Dermatitis 1989; 20:93-97.
56. De Paépe K, HachemJP, Vanpee E, et al. Beneficial effects of a skin tolerancetested moisturizing cream on the barrier function in experimentally-elicited irRITant and allergic contact dermatitis. Contact Dermatitis 2001;44:337-343.
57. Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008;121:1337-1343.
58. Szczepanowska J, Reich A, Szepietowski JC. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: A randomized comparative study. Pediatr Allergy Immunol 2008;19:614-618.
59. Perrenoud D, Gallezot D, van Melle G. The efficacy of a protective cream in a real-world apprentice hairdresser environment. Contact Dermatitis 2001;45:134-138.
60. McCormick RD, Buchman TL, Maki DG. Double-blind, randomized trial of scheduled use of a novel barrier cream and an oil-containing lotion for protecting the hands of health care workers. Am J Infect Control 2000; 28:302-310.
61. Schliemann S, Kleesz P, Elsner P. Protective creams fail to prevent solventinduced cumulative skin irRITationVresults of a randomized double blind study. Contact Dermatitis 2013;69:363-371.
62. Frosch PJ, Kurte A, Pilz B. Efficacy of skin barrier creams (III). The repetitive irRITation test (RIT) in humans. Contact Dermatitis 1993;29:113-118.
63. Frosch PJ, Schulze-Dirks A, Hoffmann M, et al. Efficacy of skin barrier creams (I). The repetitive irRITation test (RIT) in the guinea pig. Contact Dermatitis 1993;28:94-100.
64. Antonov D, Kleesz P, Elsner P, et al. Impact of glove occlusion on cumulative skin irRITation with or without hand cleanser-comparison in an experimental repeated irRITation model. Contact Dermatitis 2013;68: 293-299.
65. Winker R, Salameh B, Stolkovich S, et al. Effectiveness of skin protection creams in the prevention of occupational dermatitis: results of a randomized, controlled trial. Int Arch Occup Environ Health 2009;82: 653-662.
66. Schlüter-Wigger W, Elsner P. Efficacy of 4 commercially available protective creams in the repetitive irRITation test (RIT). Contact Dermatitis 1996;34:278-283.
67. Patterson SE, Williams JV, Marks JG Jr. Prevention of sodium lauryl sulfate irRITant contact dermatitis by Pro-Q aerosol foam skin protectant. J Am Acad Dermatol 1999;40:783-785.
68. Goh CL, Gan SL. Efficacies of a barrier cream and an after work emollient cream against cutting fluid dermatitis in metalworkers: A prospective study. Contact Dermatitis 1994;31:176-180.
69. Zhai H, Maibach HI. Effect of barrier creams: human skin in vivo. Contact Dermatitis 1996;35:92-96.
70. Sun Q, Tran M, Smith B, et al. In-situ evaluation of barrier-cream performance on human skin using laser-induced breakdown spectroscopy. Contact Dermatitis 2000;43:259-263.
71. Crosti C, Bencini PL, Brunetta F, et al. Perfluoropolyethers (Fomblin HC) for treatment of chronic irRITant contact dermatitis of the hands: A controlled study. SOFW J 1992;16:1020-1023.
72. Zhai H, Schmidt R, Levin C, et al. Prevention and therapeutic effects of a model emulsion on glove induced irRITation and dry skin in man. Occup Environ Dermatol 2002;4:134-138.
73. Modak S, Gaonkar TA, Shintre M, et al. A topical cream containing a zinc gel (allergy guard) as a prophylactic against latex glove-related contact dermatitis. Dermatitis 2005;16:22-27.
74. Held E, Sveinsdóttir S, Agner T. Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irRITants. Acta Derm Venereol 1999;79:49-51.
75. Beezhold DH, Kostyal DA, Wiseman J. The transfer of protein allergens from latex gloves. A study of influencing factors. AORN J 1994;59:605-613.